Market Overview

UPDATE: Sterne Agee Initiates Coverage on AmerisourceBergen on Dominant Market Share

Share:
Related ABC
AmerisourceBergen's PharMEDium Slows Down, Competition Rife
Opinion: Cardinal Health's Rising Dividends Make It Attractive
Valuing Uncertainties (GuruFocus)

In a report published Thursday, Sterne Agee analyst Greg T. Bolan initiated coverage on AmerisourceBergen Corp. (NYSE: ABC) with a Buy rating and $80.00 price target.

In the report, Sterne Agee noted, “With specialty drugs expected to capture an increasingly large footprint within the drug spend funnel, we believe ABC's dominant share within the specialty distribution channel will enable the company to achieve revenue growth and margins superior to those of its peers. Initiate with a Buy rating and $80 price target.”

AmerisourceBergen Corp. closed on Wednesday at $61.49.

Latest Ratings for ABC

DateFirmActionFromTo
Jan 2018Evercore ISI GroupInitiates Coverage OnOutperform
Dec 2017Goldman SachsUpgradesNeutralBuy
Dec 2017Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for ABC
View the Latest Analyst Ratings

Posted-In: Greg T. Bolan Sterne AgeeAnalyst Color Initiation Analyst Ratings

 

Related Articles (ABC)

View Comments and Join the Discussion!